The frequency of irritable bowel syndrome in primary care centers of Turkey

Öz

Background/aim: The present study was done in order to determine the frequency of irritable bowel syndrome (IBS) in primary care centers of Turkey. Materials and methods: The study was carried out by applying questionnaire in a study population of 7520 patients who were randomly selected among those admitted to primary care centers in 32 different cities of Turkey in the year 2005. The questionnaire was applied by doctors working in the primary care centers. Patients were categorized in to two groups (gastrointestinal system (GIS) or non-GIS) depending on the main symptoms on admission. The prevalence of IBS in primary care centers was investigated by applying questionnaire to 2203 randomly selected patients from both of the groups. The diagnosis of IBS was based on the Rome- II criteria. Results: Among the 7520 patients participating in the study, 2157 (31.5%) were admitted with GIS symptoms and 5363 (41%) with non-GIS symptoms. Out of 2157 patients with GIS symptoms, questionnaire was performed in randomly selected 1461 patients and a diagnosis of İBS was reached in 598 (41%). Out of 5363 patients with non-GIS symptoms, questionnaire was performed in randomly selected 742 patients and a diagnosis of İBS was reached in 141 (19%). Conclusion: This study shows that functional GIS disorders are commonly seen in our country and the patients frequently admit to doctors in the primary care centers because of the persistence of their symptoms

Anahtar Kelimeler

• Irritable bowel syndrome, prevalence, primary care, Turkey

Türkiye'de birinci basamak sağlık kurumlarında irritabl barsak sendromu görülme sıklığı

Öz

Giriş ve amaç: Bu çalışma Türkiye'de birinci basamak sağlık kurumları nda irritabl barsak sendromu (İBS) sıklığını saptamak için yapılmıştır. Gereç ve yöntem: Çalışma 2005 yılında Türkiye'nin 32 farklı ilindeki birinci basamak sağlık kuruluşuna başvuran olgular arasından rastgele seçilen 7520 olguda anket yapılarak gerçekleştirilmiştir. Anket birinci basamakta çalışan hekimler tarafından yapılmıştır. Hastalar başvurudaki ana yakınmalarına göre gastrointestinal sistem (GİS) ve GİS dışı olmak üzere iki guruba ayrıldıktan sonra, her iki gurup içinden rastgele seçilen 2203 olguya anket yapılarak birinci basamakta İBS prevalansı araştırılmı ştır. İBS tanısı Roma-II kriterlerine göre konulmuştur. Bulgular: Çalı şmaya katılan 7520 hastanın 2157'si (%31,5) GİS semptomları ile doktora başvururken, 5363'ü (%68,5) GİS dışı yakınmalar ile doktora başvurmuştur. GİS yakınmaları ile başvuran 2157 hasta arasından rastgele seçilerek anket yapılan 1461 olgunun 598'inde (%41), GİS dışı yakınmalar ile başvuran 5363 olgu arasından rastgele anket yapılan 742 olgunun 141'inde (%19) İBS tanısı konulmuştur. Sonuç: Bu çalışma ülkemizde fonksiyonel gastrointestinal hastalıkların sık görüldüğünü ve hastaları n yakınmalarının devamı nedeni ile birinci basamak hekimlerine sık başvurduklarını ortaya koymaktadır.

Anahtar Kelimeler

• İrritabl barsak sendromu, prevalans, birinci basamak, Türkiye

Kaynakça

1. Olden KW. Diagnosis of irritable bowel syndrome. Gastroentero- logy 2002; 122: 1701-14.
2. Drosman DA, Camilleri M, Mayer EA, Whitehead WE. AGA techni- cal review of irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
3. Talley NJ, Spiller R. Irrıtable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-64.
4. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of irritable bowel. BMJ; 1978: 653-4.
5. Thompson WG, Creed FH, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gastroenterology Inter- national 1992; 5: 75-91.
6. Thompson WG, Creed FH, Drossmann DA, et al. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Rich- ter JE, Talley NJ, et al, editors. The functional gastrointestinal di- sorders. Boston: Little, Brown and Company; 1994: p.115-73.
7. Thompson WG, Longstreth GF, Drosman DA, et al. Functional bo- wel disease and functional abdominal pain. Gut 1999; 45: 43-7.
8. Rome criteria process described at http: //www.romecriteria.org. Accessed March 25,2005.

9. Camilleri M, Ford MJ. Colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmocol Ther 1998; 12: 287-302.
10. Barbara G, Giorgio R, Stanghellini V, et al. New pathophysiologi- cal mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20 (Suppl 2): 1-9.
11. Ritchie R. Pain from distention of the pelvic colon by inflating a bal- loon in the irritable colon syndrome. Gut 1973; 14: 125-32.
12. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gast- roenterology 1995; 109: 40-52.
13. Corney RH, Stanton R. Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res 1990; 34: 483-91.
14. Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndro- me compared with subjects without bowel dysfunction. Gut 1992; 33: 825-30.
15. Silverman DH, Munakata JA, Ennes H, et al. Regional cerebral ac- tivation in irritable bowel syndrome and control subjects with pain- ful and non-painful rectal distention. Gastroenterology 2000; 118: 842-8.
16. Spiller RC. Postinfectious irritable bowel syndrome. Gastroentero- logy 2003; 124: 1662-71.
17. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal im- mune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
18. Barbara G, De Giorgio R, Stanghellini V, et al. A role for inflamma- tion in irritable bowel syndrome ? Gut 2002 (Suppl. 1): i41-4.
19. Balsari A, Ceccarelli A, Dubini F, et al. The fecal microbial popu- lation in the irritable bowel syndrome. Microbiologica 1982; 5: 185-94.
20. Bearcroft CP, Perrert D, Farthing MJ. Postprandial plasma 5- hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998; 42: 42-6.
21. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake trans- porter in ulcerative colitis and IBS. Gastroenterology 2004; 126: 1657-64.
22. Locke GR, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000; 75: 907-12.
23. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalance, sociodemog- raphy, and health impact. Dig Dis Sci 1993; 38: 1569-80.
24. Hahn BA, Saunders WB, Maier WC. Differences between individu- als with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997; 42: 2585-90.
25. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of co- lonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927-34.
26. Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investi- gations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2816-24.
27. Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stabi- lity over time. Gastroenterology 1995; 109: 671-80.
28. Thompson WG, Heaton KW, Smyth GT, et al. Irritable bowel syndrome in general practice: prevalance, characteristics, and re- ferral. Gut 2000: 46: 78-82.
29. Bommelaer G, Poynard T, Le Pen C, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastro- entelogie Clinique et Biologique 2004; 28: 554-61.
30. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome accor- ding to varying diagnostic criteria. Are the new Rome II criteria un- neccessarily restrictive for research and practice ? Am J Gastroen- terol 2000; 95: 3176-83.
31. Jones R, Lydeard S. Irritable bowel syndrome in the general popu- lation. BMJ 1992; 304: 87-90.
32. Wilson S, Roberts L, Roalfe A, et al. Prevalance of irritable bowel syndrome : a community survey. Br J Gen Pract 2004; 54: 495-502.
33. Merain F, Badia X, Balboa A, et al. Irritable bowel syndrome pre- valance varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a gene- ral population. Scand J Gastroenterol 2001; 36: 1155-61.
34. Gwee KA, Wee S, Wong ML, et al. The prevalance, symptom charac- teristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004; 99: 924-31.
35. Xiong LS, Chen MH, Chen HX, et al. A population-based epidemi- ologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004; 19: 1217-24.
36. Kwan AC, Hu WH, Chan YK, et al. Prevalance of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol 2002; 17: 1180-6.
37. Rajendra S, Alahuddin S. Prevalance of irritable bowel syndrome in a multi-ethnic Asian population. Aliment Pharmacol Ther 2004; 19: 704-6.
38. Masud MA, Hasan M, Khan AG. Irritable bowel syndrome in a rural community in Bangladesh: prevalance, symptoms pattern, and health care seeking behaviour. Am J Gastroenterol 2001; 96: 1547-52.
39. Lau EM, Chan FK, Ziea ET, et al. Epidemiology of irritable bowel syndrome in Chineese. Dig Dis Sci 2002; 47: 2621-4.
40. Pan G, Lu S, Ke M, et al. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster samp- ling. Chin Med J 2000; 113: 35-9.
41. Ho KY, Kang JY, Seow A. Prevalance of gastrointestinal symptoms in a multi-racial Asian population with particular reference to ref- lux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
42. Çelebi S, Açık Y, Deveci SE, et al. Epidemiological features of irri- table bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004; 19: 738-743.
43. Karaman N, Türkay C, Yönem Ö. Irritable bowel syndrome preva- lence in city center of Sivas. Turk J Gastroenterol 2003; 14: 128-31.
44. Akpınar H, Kılıç B, Amanvermez D, et al. Prevalence of irritable bo- wel syndrome in İzmir Narlıdere region. Turk J Gastroenterol 1999; 10 (Suppl.2): 21.
45. Yılmaz Ş, Dursun M, Ertem M, et al. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified ran- domised community-based study. Int J Clin Pract 2005; 59: 361-9.
46. Mitchell CM, Drossman DA. Survey of the AGA membership rela- ting to patients with functional gastrointestinal disorders. Gastroen- terology 1987; 92: 1282-4.
47. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndro- me: a technical review for practice guideline development. Gastro- enterology 1997; 112: 2120-37.
48. Switz DM. What the gastroenterologist does all day: a survey of a state society’s practice. Gastroenterology 1976; 70: 1048-50.
49. American Gastroenterological Association. The burden of gastroin- testinal diseases. Bethesda MD. American Gastroenterological Press, 2002.
50. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in commu- nity subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736-41.
51. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122:
52. Royal College of General Practitioners, OPCS and DHSS. Morbi- dity statistics from general practice 1991-1992. Fourth National Study, Studies on Medical and Population Subjects. London: HMSO,1995.
53. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
54. Locke GR. Prevalance, incidence and natural history of dyspepsia and functional dyspepsia. Baillieres Clin Gastroenterol 1998; 12: 435-42.
55. Stanghellini V, Tosetti C, Barbara G, et al. Management of dyspep- tic patients by general practitioners and specialists. Gut 1998; 43 (Suppl 1): S21-23.
56. Talley NJ, Weaver AL, Zinsmeister AR, et al. Onset and disappe- arance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
57. Jones RH, Lydeard SE, Hobbs FDR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
58. Agreus L, Svardsudd K, Nyren O, et al. Prevalence of dyspepsia and demographic characteristics in a Swedish adult population. Scand J Gastroenterol 1994; 29: 102-9.
59. Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994; 29: 1-6.
60. Papatheodoridis GV, Karamanolis DG. Prevalence and impact of upper and lower gastrointestinal symptoms in the greek urban gene- ral population. Scand J Gastroenterol 2005; 40: 412-21.
61. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495-8.
62. Maconi G, Tosetti C, Stanghellini V, et al. Dyspeptic symptoms in primary care. An observational study in general practice. Eur J Gastroenterol Hepatol 2002; 14: 985-90.
63. van Bommel MJJ, Numans ME, Wit NJ, et al. Consultations and re- ferrals for dyspepsia in a general practice-a one year database sur- vey. Postgrad Med J 2001; 77: 514-8.
64. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United states. Gastroenterology 1991; 100: 998- 1005.
65. Russo MW, Gaynes BN, Drossman DA. A national survey of practi- ce patterens of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 1999; 29: 339-43.
66. Thompson WG, Heaton KW. Functional bowel disorders in appa- rently healthy people. Gastroenterology 1980; 79: 283-8.
67. Drossman DA, Sandler RS, McKee MC, et al. Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982; 83: 529-34.
68. Müller-Lissner SA, Bollani S, Brummer RJ, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001; 64: 200-4.
69. Locke GR, Yawn BP, Wollan PC, et al. The incidence of clinically diagnosed irritable bowel syndrome in the community. Gastroente- rology 1999; 116: A52.
70. Koloski NA, Tally NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical re- view of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001; 96: 1340-9.
71. Giorgio R, Barbara G, Stanghellini V, et al. Diagnosis and therapy of irritable bowel syndrome. Aliment Phramacol Ther 2004; 20 (Suppl 2): 10-22
72. Hungin APS, Chang L, Locke GR, et al. Irrıtable bowel syndrome in the United States: prevalence, symptom patterns and impact. Ali- ment Pharmacol Ther 2005; 21: 1365-75.
73. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demograp- hics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22: 935-42.
74. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipati- on: review and what’s new. Rev Gastroenterol Disord 2001; 1: 2-17.
75. Agreus, Svardsudd K, Talley NJ, et al. Natural history of gastro- esophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96: 2905-14.
76. Halder SL, Locke GR, Talley NJ, et al. Impact of functional gastro- intestinal disorders on health-related quality of life: a population- based case-control study. Aliment Pharmacol Ther 2004; 1519: 233-42.
77. Stanghellini V, Tosetti C, Barbara G, et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroente- rol 2002; 97: 2738-43.
78. Holtmann G, Goebell Hi Talley NJ. Functional dyspepsia and irri- table bowel syndrome. İs there a common pathophysiologic basis? Am J Gastroenterol 1997; 92: 954-9.
79. Cremonini F, Talley NJ. Review article: the overlap between functi- onal dyspepsia and irritable bowel syndrome-a tale of one or two di- sorders. Aliment Pharmacol Ther 2004; 20 (Suppl 7): 40-49.
80. Talley NJ, Dennis EH, Duncan AS, et al. Overlapping upper and lo- wer gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003; 98: 2454-9.
81. Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Guti- errez JM, et al. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med 1999; 26: 404-9.
82. Tjeerdsma HC, Smout AJ, Akkermans LM. Voluntary suppresion of defecation delays gastric emptying. Dig Dis Sci 1993; 38: 832-6.
83. Dainese R, Galliani EA, De Lazzari F, et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 1892-7.
84. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome ? Am J Gastroenterol 1998; 93: 2184-90.
85. van der Horst HE, van Dulman AM, Schellevis FG, et al. Do pati- ents with irritable bowel syndrome in primary care differ from out- patients with irritable bowel syndrome ?Gut 1997; 41: 669-74.
86. Vagero D, Leon D. Effect of social class in childhood and adultho- od on adult mortality. Lancet 1994; 343: 1224-5.
87. Mendall MA, Kumar D. Antibiotic use, childhood affluence and ir- ritable bowel syndrome. Eur J Gastroenterol Hepatol 1998; 10: 59-62.
88. Howell S, Talley NJ, Quine S, et al. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004; 99: 1572-8.
89. Talley NJ, Zinsmeister AR, Melton LJ. Irrıtable bowel syndrome in a community: symptom subgroups, risk factors and health care uti- lization. Am J Epidemiol 1995; 142: 76-83.
90. Koloski NA, Talley NJ, Huskic SS, et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003; 17:
91. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut 1997; 41: 394-8.
92. Hungin APS, Whorwell JT, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
93. Kennedy TM, Jones RH. Epidemiology of cholecystectomy and irri- table bowel syndrome in a UK population. Br J Surg 2000; 87: 1658-63
94. Longstreth GF, Preskill DB, Youkeles L. IBS in women having diag- nostic laparoscopy or hysterectomy: Relation to gynecologic featu- res and outcome. Dig Dis Sci 1990; 35: 1285-90.
95. Burns DG. The risk of abdominal surgery in IBS. S Af Med J 1986; 70: 91.
96. Longstreth GF, Yao JF. Irrıtable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2004; 126: 1665-73.
97. Olden K, Chey W, Boyle J, et al. Health-related quality of life in IBS. A community based study. Gastroenterology 2001; 120: A634.